Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1990 Feb 15;266(1):273–282. doi: 10.1042/bj2660273

Purification and characterization of heparin-binding growth factors from porcine uterus.

D R Brigstock 1, R B Heap 1, P J Barker 1, K D Brown 1
PMCID: PMC1131124  PMID: 2310377

Abstract

Heparin-binding growth factors present in pig uterine tissue were purified by approx. 50,000-fold using a combination of ammonium sulphate precipitation, ion-exchange chromatography and heparin-affinity chromatography. Purification of the uterus-derived growth factors (UDGFs) was monitored by the stimulation of [3H]thymidine incorporation into Swiss 3T3 cells and by a radioreceptor assay using 125I-labelled epidermal growth factor (EGF) as the ligand. The latter was shown to be a novel, rapid and reliable assay for heparin-binding growth factors which utilizes their trans-modulation of EGF receptor affinity. UDGFs exhibit strong affinity for immobilized heparin and two forms, named alpha UDGF and beta UDGF, were distinguished by salt gradient elution from heparin-agarose affinity columns. beta UDGF activity was eluted from heparin-agarose between 1.5 M- and 1.8 M-NaCl, and was correlated with the elution of a protein doublet of 17.2 kDa and 17.7 kDa. Immunoblotting of heparin-purified beta UDGF indicated that the beta UDGF doublet is immunologically related to the 146-amino-acid form of bovine basic fibroblast growth factor (bFGF), and that the 17.2 kDa component is an N-terminally truncated form of the 17.7 kDa component. After purification by C4 reversed-phase h.p.l.c., this doublet was biologically active and greater than 95% pure as assessed by silver-stained SDS/PAGE. Amino acid composition and sequence analysis confirmed that these beta UDGF polypeptides were microheterogeneous forms of bFGF. Fractions containing alpha UDGF activity were eluted from heparin-agarose in 1.3 M-NaCl. These fractions contained a 16.5 kDa protein which co-migrated on SDS/polyacrylamide gels with recombinant human acidic FGF (aFGF) and which which cross-reacted with an antiserum raised against aFGF. The identification of heparin-binding growth factors in porcine uterus at the time of implantation raises the possibility that they function in the reproductive tract during early pregnancy.

Full text

PDF
273

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham J. A., Whang J. L., Tumolo A., Mergia A., Friedman J., Gospodarowicz D., Fiddes J. C. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J. 1986 Oct;5(10):2523–2528. doi: 10.1002/j.1460-2075.1986.tb04530.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baird A., Esch F., Mormède P., Ueno N., Ling N., Böhlen P., Ying S. Y., Wehrenberg W. B., Guillemin R. Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog Horm Res. 1986;42:143–205. doi: 10.1016/b978-0-12-571142-5.50008-2. [DOI] [PubMed] [Google Scholar]
  3. Baird A., Hsueh A. J. Fibroblast growth factor as an intraovarian hormone: differential regulation of steroidogenesis by an angiogenic factor. Regul Pept. 1986 Dec 30;16(3-4):243–250. doi: 10.1016/0167-0115(86)90023-6. [DOI] [PubMed] [Google Scholar]
  4. Bird R. C., Bartol F. F., Daron H., Stringfellow D. A., Riddell M. G. Mitogenic activity in ovine uterine fluids: characterization of a growth factor activity which specifically stimulates myoblast proliferation. Biochem Biophys Res Commun. 1988 Oct 14;156(1):108–115. doi: 10.1016/s0006-291x(88)80811-8. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Brigstock D. R., Heap R. B., Brown K. D. Polypeptide growth factors in uterine tissues and secretions. J Reprod Fertil. 1989 Mar;85(2):747–758. doi: 10.1530/jrf.0.0850747. [DOI] [PubMed] [Google Scholar]
  7. Brown K. D., Blakeley D. M. Inhibition of the binding of 125I-labelled epidermal growth factor to mouse cells by a mitogen in goat mammary secretions. Biochem J. 1983 May 15;212(2):465–472. doi: 10.1042/bj2120465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brown K. D., Blakeley D. M., MacDonald M. Inhibition of epidermal growth factor binding to Swiss 3T3 cells by human platelet release-products. Biosci Rep. 1983 Jul;3(7):659–666. doi: 10.1007/BF01172876. [DOI] [PubMed] [Google Scholar]
  9. Brown K. D., Blay J., Irvine R. F., Heslop J. P., Berridge M. J. Reduction of epidermal growth factor receptor affinity by heterologous ligands: evidence for a mechanism involving the breakdown of phosphoinositides and the activation of protein kinase C. Biochem Biophys Res Commun. 1984 Aug 30;123(1):377–384. doi: 10.1016/0006-291x(84)90424-8. [DOI] [PubMed] [Google Scholar]
  10. Burgess W. H., Mehlman T., Marshak D. R., Fraser B. A., Maciag T. Structural evidence that endothelial cell growth factor beta is the precursor of both endothelial cell growth factor alpha and acidic fibroblast growth factor. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7216–7220. doi: 10.1073/pnas.83.19.7216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Collins M. K., Sinnett-Smith J. W., Rozengurt E. Platelet-derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells. J Biol Chem. 1983 Oct 10;258(19):11689–11693. [PubMed] [Google Scholar]
  12. Crabb J. W., Armes L. G., Carr S. A., Johnson C. M., Roberts G. D., Bordoli R. S., McKeehan W. L. Complete primary structure of prostatropin, a prostate epithelial cell growth factor. Biochemistry. 1986 Sep 9;25(18):4988–4993. doi: 10.1021/bi00366a003. [DOI] [PubMed] [Google Scholar]
  13. Davis R. J., Czech M. P. Inhibition of the apparent affinity of the epidermal growth factor receptor caused by phorbol diesters correlates with phosphorylation of threonine-654 but not other sites on the receptor. Biochem J. 1986 Jan 15;233(2):435–441. doi: 10.1042/bj2330435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Davis R. J., Czech M. P. Stimulation of epidermal growth factor receptor threonine 654 phosphorylation by platelet-derived growth factor in protein kinase C-deficient human fibroblasts. J Biol Chem. 1987 May 15;262(14):6832–6841. [PubMed] [Google Scholar]
  15. Delli-Bovi P., Curatola A. M., Newman K. M., Sato Y., Moscatelli D., Hewick R. M., Rifkin D. B., Basilico C. Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol. 1988 Jul;8(7):2933–2941. doi: 10.1128/mcb.8.7.2933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. DiAugustine R. P., Petrusz P., Bell G. I., Brown C. F., Korach K. S., McLachlan J. A., Teng C. T. Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology. 1988 Jun;122(6):2355–2363. doi: 10.1210/endo-122-6-2355. [DOI] [PubMed] [Google Scholar]
  17. Esch F., Baird A., Ling N., Ueno N., Hill F., Denoroy L., Klepper R., Gospodarowicz D., Böhlen P., Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6507–6511. doi: 10.1073/pnas.82.19.6507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Flint A. P. A unifying hypothesis for the control of blastocyst growth based on observations of the pig. J Reprod Fertil Suppl. 1981;29:215–227. [PubMed] [Google Scholar]
  19. Folkman J., Klagsbrun M. Angiogenic factors. Science. 1987 Jan 23;235(4787):442–447. doi: 10.1126/science.2432664. [DOI] [PubMed] [Google Scholar]
  20. Friedman B. A., Rosner M. R. Growth factors modify the epidermal growth factor receptor through multiple pathways. J Cell Biochem. 1987 May;34(1):1–11. doi: 10.1002/jcb.240340102. [DOI] [PubMed] [Google Scholar]
  21. Fuchs A., Lindenbaum E., Marcoudas N. G. Location of the angiogenic activity in the pregnant human uterus. Acta Anat (Basel) 1985;124(3-4):241–244. doi: 10.1159/000146123. [DOI] [PubMed] [Google Scholar]
  22. Gautschi-Sova P., Jiang Z. P., Fràter-Schröder M., Böhlen P. Acidic fibroblast growth factor is present in nonneural tissue: isolation and chemical characterization from bovine kidney. Biochemistry. 1987 Sep 8;26(18):5844–5847. doi: 10.1021/bi00392a039. [DOI] [PubMed] [Google Scholar]
  23. Glenney J. Antibody probing of western blots which have been stained with india ink. Anal Biochem. 1986 Aug 1;156(2):315–319. doi: 10.1016/0003-2697(86)90259-9. [DOI] [PubMed] [Google Scholar]
  24. Gospodarowicz D., Cheng J., Lui G. M., Baird A., Böhlent P. Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci U S A. 1984 Nov;81(22):6963–6967. doi: 10.1073/pnas.81.22.6963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Gospodarowicz D., Ferrara N., Schweigerer L., Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 1987 May;8(2):95–114. doi: 10.1210/edrv-8-2-95. [DOI] [PubMed] [Google Scholar]
  26. Hauschka P. V., Mavrakos A. E., Iafrati M. D., Doleman S. E., Klagsbrun M. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem. 1986 Sep 25;261(27):12665–12674. [PubMed] [Google Scholar]
  27. Ikeda T., Sirbasku D. A. Purification and properties of a mammary-uterine-pituitary tumor cell growth factor from pregnant sheep uterus. J Biol Chem. 1984 Apr 10;259(7):4049–4064. [PubMed] [Google Scholar]
  28. Kimelman D., Abraham J. A., Haaparanta T., Palisi T. M., Kirschner M. W. The presence of fibroblast growth factor in the frog egg: its role as a natural mesoderm inducer. Science. 1988 Nov 18;242(4881):1053–1056. doi: 10.1126/science.3194757. [DOI] [PubMed] [Google Scholar]
  29. Klagsbrun M., Smith S., Sullivan R., Shing Y., Davidson S., Smith J. A., Sasse J. Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases. Proc Natl Acad Sci U S A. 1987 Apr;84(7):1839–1843. doi: 10.1073/pnas.84.7.1839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kurokawa T., Seno M., Igarashi K. Nucleotide sequence of rat basic fibroblast growth factor cDNA. Nucleic Acids Res. 1988 Jun 10;16(11):5201–5201. doi: 10.1093/nar/16.11.5201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lin C. R., Chen W. S., Lazar C. S., Carpenter C. D., Gill G. N., Evans R. M., Rosenfeld M. G. Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms. Cell. 1986 Mar 28;44(6):839–848. doi: 10.1016/0092-8674(86)90006-1. [DOI] [PubMed] [Google Scholar]
  32. Lobb R. R., Fett J. W. Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. Biochemistry. 1984 Dec 18;23(26):6295–6299. doi: 10.1021/bi00321a001. [DOI] [PubMed] [Google Scholar]
  33. Lobb R. R., Harper J. W., Fett J. W. Purification of heparin-binding growth factors. Anal Biochem. 1986 Apr;154(1):1–14. doi: 10.1016/0003-2697(86)90487-2. [DOI] [PubMed] [Google Scholar]
  34. Magnaldo I., L'Allemain G., Chambard J. C., Moenner M., Barritault D., Pouysségur J. The mitogenic signaling pathway of fibroblast growth factor is not mediated through polyphosphoinositide hydrolysis and protein kinase C activation in hamster fibroblasts. J Biol Chem. 1986 Dec 25;261(36):16916–16922. [PubMed] [Google Scholar]
  35. Mormède P., Baird A., Pigeon P. Immunoreactive fibroblast growth factor (FGF) in rat tissues: molecular weight forms and the effects of hypophysectomy. Biochem Biophys Res Commun. 1985 May 16;128(3):1108–1113. doi: 10.1016/0006-291x(85)91054-x. [DOI] [PubMed] [Google Scholar]
  36. Moscatelli D., Joseph-Silverstein J., Manejias R., Rifkin D. B. Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5778–5782. doi: 10.1073/pnas.84.16.5778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Murphy L. J., Friesen H. G. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology. 1988 Jan;122(1):325–332. doi: 10.1210/endo-122-1-325. [DOI] [PubMed] [Google Scholar]
  38. Ogasawara M., Karey K. P., Marquardt H., Sirbasku D. A. Identification and purification of truncated insulin-like growth factor I from porcine uterus. Evidence for high biological potency. Biochemistry. 1989 Mar 21;28(6):2710–2721. doi: 10.1021/bi00432a052. [DOI] [PubMed] [Google Scholar]
  39. Olashaw N. E., Pledger W. J. Heterologous regulation of EGF receptors in fibroblastic cells. J Cell Biochem. 1987 Jun;34(2):143–149. doi: 10.1002/jcb.240340208. [DOI] [PubMed] [Google Scholar]
  40. Pollard J. W., Bartocci A., Arceci R., Orlofsky A., Ladner M. B., Stanley E. R. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature. 1987 Dec 3;330(6147):484–486. doi: 10.1038/330484a0. [DOI] [PubMed] [Google Scholar]
  41. Presta M., Rusnati M., Maier J. A., Ragnotti G. Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form. Biochem Biophys Res Commun. 1988 Sep 30;155(3):1161–1172. doi: 10.1016/s0006-291x(88)81262-2. [DOI] [PubMed] [Google Scholar]
  42. Rice C., Ackland N., Heap R. B. Blastocyst-endometrial interactions and protein synthesis during pre-implantation development in the pig studied in vitro. Placenta. 1981 Apr-Jun;2(2):129–142. doi: 10.1016/s0143-4004(81)80016-1. [DOI] [PubMed] [Google Scholar]
  43. Roberts R. M., Bazer F. W. The functions of uterine secretions. J Reprod Fertil. 1988 Mar;82(2):875–892. doi: 10.1530/jrf.0.0820875. [DOI] [PubMed] [Google Scholar]
  44. Rubin J. S., Osada H., Finch P. W., Taylor W. G., Rudikoff S., Aaronson S. A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A. 1989 Feb;86(3):802–806. doi: 10.1073/pnas.86.3.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Savage C. R., Jr, Cohen S. Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J Biol Chem. 1972 Dec 10;247(23):7609–7611. [PubMed] [Google Scholar]
  46. Schlessinger J. Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol. 1986 Dec;103(6 Pt 1):2067–2072. doi: 10.1083/jcb.103.6.2067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Shimasaki S., Emoto N., Koba A., Mercado M., Shibata F., Cooksey K., Baird A., Ling N. Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem Biophys Res Commun. 1988 Nov 30;157(1):256–263. doi: 10.1016/s0006-291x(88)80041-x. [DOI] [PubMed] [Google Scholar]
  48. Simmen R. C., Ko Y., Liu X. H., Wilde M. H., Pope W. F., Simmen F. A. A uterine cell mitogen distinct from epidermal growth factor in porcine uterine luminal fluids: characterization and partial purification. Biol Reprod. 1988 Apr;38(3):551–561. doi: 10.1095/biolreprod38.3.551. [DOI] [PubMed] [Google Scholar]
  49. Slack J. M., Darlington B. G., Heath J. K., Godsave S. F. Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature. 1987 Mar 12;326(6109):197–200. doi: 10.1038/326197a0. [DOI] [PubMed] [Google Scholar]
  50. Sommer A., Brewer M. T., Thompson R. C., Moscatelli D., Presta M., Rifkin D. B. A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun. 1987 Apr 29;144(2):543–550. doi: 10.1016/s0006-291x(87)80001-3. [DOI] [PubMed] [Google Scholar]
  51. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Ueno N., Baird A., Esch F., Ling N., Guillemin R. Isolation of an amino terminal extended form of basic fibroblast growth factor. Biochem Biophys Res Commun. 1986 Jul 31;138(2):580–588. doi: 10.1016/s0006-291x(86)80536-8. [DOI] [PubMed] [Google Scholar]
  53. Walker F., Burgess A. W. Transmodulation of the epidermal-growth-factor receptor in permeabilized 3T3 cells. Biochem J. 1988 Nov 15;256(1):109–115. doi: 10.1042/bj2560109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wray W., Boulikas T., Wray V. P., Hancock R. Silver staining of proteins in polyacrylamide gels. Anal Biochem. 1981 Nov 15;118(1):197–203. doi: 10.1016/0003-2697(81)90179-2. [DOI] [PubMed] [Google Scholar]
  55. Yoshida T., Miyagawa K., Odagiri H., Sakamoto H., Little P. F., Terada M., Sugimura T. Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7305–7309. doi: 10.1073/pnas.84.20.7305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Zhan X., Bates B., Hu X. G., Goldfarb M. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol Cell Biol. 1988 Aug;8(8):3487–3495. doi: 10.1128/mcb.8.8.3487. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES